Imminent global problems in lung cancer require joint action: time for an international alliance!

Hot topics
Chairs: M. Gaga (Athens, Greece), J. van Meerbeeck (Edegem (Antwerp), Belgium)
Aims: Lung cancer constitutes a substantial global burden for not just patients but also professionals and healthcare systems. Multiple scientific international and national initiatives are tackling the various problems associated with this debilitating and still deadly disease. ALA/ATS , ESMO, IASLC, JRS and ERS will highlight the most recent aspects of care from their individual perspectives, with the aim of building an international lung cancer alliance.

Key issues in optimising and implementing low-dose computed tomography lung cancer-screening programmes D. Baldwin (Nottingham (Nottinghamshire), United Kingdom)
The ALA/ATS implementation guide on lung cancer screening C. Thomson (Boston, United States of America)
IASLC PD-L1 Blueprint Project F. Hirsch (Aurora, United States of America)
The Asian experience in co-existing lung cancer and interstitial lung disease Y. Nakanishi (Fukuoka, Japan)
Lung cancer immunotherapy S. Peters (Lausanne, Switzerland)